Home Healthcare Cell Culture Market
cell culture market

Cell Culture Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By End-Use; By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Forecast, 2022 - 2030

  • Published Date: Oct 2022
  • Pages: 118
  • Format: PDF
  • Report ID: PM1013
  • Base Year: 2021
  • Historical Data: 2018-2020

Report Summary

The global cell culture market was valued at USD 22.16 billion in 2021 and is expected to grow at a CAGR 12.0% during the forecast period. The growing demand for cell culture is expected to be driven by the increasing instances of chronic illness and R&D expenditure to develop monoclonal antibodies to cure these diseases.

Cell Culture Market Size
Know more about this report: Request for sample pages

Awareness of cell-culture-based vaccines due to their effectiveness in treating certain diseases is also a significant factor contributing to the cell culture market growth. These vaccines replace conventional vaccines as they eliminate contamination and mismatch among strains during manufacturing.

In addition, an adequate supply of mammalian cells is required to manufacture these vaccines, which has increased their demand in many pharmaceutical companies and laboratories. Moreover, viral and fungal infections are treated with cell-based vaccines, influencing the industry growth.

The COVID-19 pandemic has influenced the growth of the cell culture market as it played a significant role in identifying many innovative diagnostic and treatment solutions to treat the SARS-CoV-2 virus. In addition, many pharmaceutical and biotechnological companies collaborated to develop antiviral drugs. For instance, GlaxoSmithKline plc partnered with Vir Biotechnology, Inc. to purchase 600,000 doses of sotrovimab, an investigational monoclonal antibody used in the early treatment of covid-19.

However, cell culture mainly relies on plastic consumables generating large amounts of plastic waste and polluting the environment, which is expected to hamper the market growth. Moreover, rising expenses to store high-quality samples and increasing equipment prices make it unaffordable for small-scale companies to perform this method which is expected to restrain industry growth.

Industry Dynamics

Growth Drivers
Rising infectious and chronic diseases such as influenza and cancer among the geriatric population are expected to drive the industry. Additionally, advancement in cell technology has resulted in the development of various drugs and personalized medicine. The cell behavior can be easily monitored and controlled in the micro-environment with the use of the 3D cell culture method, which allows the growth of two different cell populations with co-culture, which is effective for cancer treatment and therefore, propelling the market growth.

In addition, the adoption of regenerative therapies for transplantation in the healthcare sector is also contributing to the market growth owing to the treat organ and tissue failures. In addition, regenerative medicines also have a huge demand in baby boomers as it relieves pain caused by sprained ligament, strained muscles, and knee osteoarthritis, which is supporting the market growth.

Report Segmentation

The market is primarily segmented based on product, application, end-use, and region.

By Product

By Application

By End-Use

By Region

  • By Consumable
    • Sera
    • Media
    • Reagents
    • Vessels
      • Roller/Roux Bottles
      • Cell Factory Systems/Cell Stacks
      • Multiwell Plates
      • Flasks
      • Petri Dishes
    • Accessories
  • By Equipment
      • Supporting Equipment
      • Bioreactors
      • Storage Equipment
  • Drug Discovery & Development
  • Tissue Culture & Regenerative Medicine
    • Cell And Gene Therapy
    • Others
  • Biopharmaceutical Production
    • Monoclonal Antibodies
    • Vaccines Production
    • Other Therapeutic Proteins
  • Diagnostics
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report: Request for sample pages

Consumables accounted for the largest share in 2021

Consumables segment accounted for the largest share, owing to their application in biopharmaceutical companies, academic research, and contract research institutes. In addition, the prevalence of many infectious diseases & chronic diseases such as cancer and stem cell transplant has increased the demand for personalized medicines which is expected to drive the market.

Moreover, the media segment is expected to lead the market as it eliminates contamination between samples and ensures precise cell culture, which has huge demand in life science, chemistry, and various end-use industries supporting the segment's growth.

Biopharmaceutical production is expected to witness the fastest growth

Biopharmaceutical production is expected to witness the fastest growth over the forecast period due to the consumption of cell culture for medical screening and extensive compound synthesis. The increasing use of mammalian cell lines in the manufacturing pharmaceutical product is the primary factor influencing the market.

In addition, government support to develop cell culture-based vaccines due to rising monoclonal disorders and their effectiveness in curing this illness is also expected to accelerate the market.

Pharmaceutical and biotechnological companies is expected to lead the market

The demand for pharmaceutical and biotechnological companies is expected to surge significantly over the forecast period owing to the increasing consumption of cell culture-based products in commercial as well as academic & research bio-production. The rising R&D expenditure to develop new antibody therapeutics and drugs are also a factor supporting the growth of the market.

Moreover, numerous companies are adopting artificial intelligence to monitor cell development and majorly for drug screening for cancer, tuberculosis, and many more. For instance, the researcher at Vancouver Prostate center developed an AI-driven App named SnapCyte for cell culture growth. The app collects the sample, monitors cell development over time, and displays accurate cell data; these factors support segment growth.

North America to dominate and witness the fastest growth over the forecast period

North America is the largest region for cell culture and is expected to continue its dominance over the forecast period owing to the rising chronic disease in the geriatric population. In addition, technological advancement in biopharmaceutical centers and government initiatives and policies to develop medical research is contributing to the segment growth.

Asia Pacific is expected to be the second largest region for the cell culture market on account of the rising government investment in the healthcare sector owing to increasing cases of cancer and diabetes, as well as brain injuries in developing economies such as India, China, and Japan.

Furthermore, major key companies focusing more on developing gene therapies create a lucrative opportunity for clinical research, which is likely to have a positive impact on revenue growth.

Competitive Insight

Some of the major players operating in the global market include Angus Chemical company, Adolf Kuhner, Biospherix, Caisson Laboratories Inc., Corning Incorporated, Dickinson and company, Danaher Corporation, Eppendorf AG, Fujifilm Irvine Scientific, Inc., Getinge AB, Meissner Filtration Products inc., Miltenyi Biotec, Himedia laboratories, Merck KGaA, Pan-Biotech GmbH, Lonza Group AG, SeraCare Life Sciences Inc., Stemcell Technologies Inc., Sartorius AG, ThermoFisher Scientific Inc.

Recent Developments

In September2022, Adolf Kuhner launched a new orbitally shaken bioreactor SB10-X which has a capacity of up to 3L. This vessel allows working with small units of 1.5-4.5L, which is used to perform cell culture.

In May 2022, Danaher Corporation partnered with Bespoke Gene Therapy Consortium to create gene therapy resources that are cost-efficient and more convenient for the research community to develop various drugs for rare diseases.

Cell Culture Market Report Scope

Report Attributes

Details

Market size value in 2022

USD 25.48 billion

Revenue forecast in 2030

USD 63.17 billion

CAGR

12.0% from 2022 - 2030

Base year

2021

Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD billion and CAGR from 2022 to 2030

Segments covered

By Product, By Application, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Angus Chemical company, Adolf Kuhner, Biospherix, Caisson Laboratories Inc., Corning Incorporated, Dickinson and company, Danaher Corporation, Eppendorf AG, Fujifilm Irvine Scientific, Inc., Getinge AB, Meissner Filtration Products inc., Miltenyi Biotec, Himedia laboratories, Merck KGaA, Pan-Biotech GmbH, Lonza Group AG, SeraCare Life Sciences Inc., Stemcell Technologies Inc., Sartorius AG, ThermoFisher Scientific Inc.

Key Take-Away
Polaris Market Research
Global Cell Culture Market Size Report, 2022 - 2030